STRONGBRIDGE BIOPHARMA plc — Operating Income by Fiscal Year
8 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/2512031e-696a-4aa8-965b-7007c61f20af/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2020 | $-43.2M | 2020-01-01 – 2020-12-31 | evidence 0001558370-21-002288 |
| FY 2019 | $-67.1M | 2019-01-01 – 2019-12-31 | evidence 0001558370-20-001720 |
| FY 2018 | $-81.9M | 2018-01-01 – 2018-12-31 | evidence 0001558370-19-001146 |
| FY 2017 | $-73.7M | 2017-01-01 – 2017-12-31 | evidence 0001558370-18-001865 |
| FY 2016 | $-50.7M | 2016-01-01 – 2016-12-31 | evidence 0001558370-17-002430 |
| FY 2015 | $-42.9M | 2015-01-01 – 2015-12-31 | evidence 0001558370-16-004373 |
| FY 2014 | $-10.4M | 2014-01-01 – 2014-12-31 | evidence 0001558370-16-004373 |
| FY 2013 | $-5.2M | 2013-01-01 – 2013-12-31 | evidence 0001558370-16-004373 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
STRONGBRIDGE BIOPHARMA plc — all facts · Revenue · Net Income